Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06251323 · ClinicalTrials.gov registry record · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
A NA study of Diabetes Mellitus, Type 2, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 119,680
- Enrollment target
- 4
- Study locations
NCT06251323: Recruiting NA study of Diabetes Mellitus, Type 2, sponsored by Stanford University.
NCT06251323 is a NA study of Diabetes Mellitus, Type 2 that is actively recruiting participants, run by Stanford University. The registered enrollment target is 119,680 participants, above the 4,141-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (2790% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06251323, a NA study of Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 119,680 participants
- Enrollment target
- 4
- Study locations
Study Summary
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.
Primary Outcome
Percent poorly controlled diabetes (A1c\>9%)
Conditions Studied
Interventions
- OTHER iPATH implementation approach
Study Locations (4)
California
- Board of Trustees of the Leland Stanford Junior University - Stanford
Massachusetts
- President and Fellows of Harvard College, T.H. Chan School - Boston
Ohio
- The Ohio State University - Columbus
Puerto Rico
- Impactivo, LLC. - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119,680 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT06251323 shows while recruiting
NCT06251323 is an interventional study that assigns participants to a tested intervention. Its 119,680 participants enrollment target places it among the larger protocols in the corpus, above the 4,141-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (2790% higher).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which iPATH implementation approach is the first listed.
NCT06251323 reports a single indexed study location in California, Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT06251323 about?
NCT06251323 is a clinical study titled "Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)". Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will ...
What is the current status of trial NCT06251323?
This trial is currently recruiting. It is a NA study. The enrollment target is 119,680 participants. The study started on 2025-09-30. Estimated completion is 2028-01-31.
What conditions does trial NCT06251323 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT06251323?
The interventions under investigation include: iPATH implementation approach (OTHER).
Who is sponsoring clinical trial NCT06251323?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06251323 being conducted?
This trial has 4 study locations across California, Massachusetts, Ohio, Puerto Rico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06251323's enrollment target sits among peer trials
119,680 4th of 348 higher than 345 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI